DEXWireNews

EFFI is our new Healthcare/Tech alert with Huge Upside Potential

Long
OTC:EFFI   None
========================
Efftec International, Inc. (EFFI)

Alert Price: $0.09

Chart Analysis

Must Hear CEO Interview

Company Website | Recent News
========================


Members,

We've been one of the hottest financial publications in the industry as of late.

Over the past few weeks our trade ideas have given our members the opportunity to secure over +300% in realistic gains.

What's most impressive is that this has all been done in one of the most volatile markets that we have seen in quite some time.

We now have another exciting trade idea that should be right up your alley.

Please turn your immediate attention to Efftec International, Inc. (EFFI).

Over the past two weeks shares of EFFI are quietly up over +125%, and we believe that the momentum is just getting started.

The Company closed out today's session up over +21% on light volume , but we believe tomorrow could bring an even bigger move.

We've looked into the trading history of EFFI, and it appears to move on air.

Back on April 24th, shares of EFFI more than doubled on light volume .

The Company is still well off from its 52-week high of $0.35, so this bullish reversal still has plenty of room to run.

In fact, run back to its 52-week high from today's alert price would net traders over +288% in realistic profit from today's alert price.
This is an exciting time for the Company...

In a recent interview with SmallCapVoice.com, EFFI CEO Paul Cristiano appeared optimistic regarding EFFI's shift in business model, and stated that to better reflect its new technology-related business model EffTec International is in the process of changing its name to “Nexteligent Holdings, Inc.” and will secure a new ticker symbol.

EFFI also received $320,000 equity investment from 32Group Inc. at $0.15 per share.

About EffTec International, Inc.

EffTec International, Inc. (EFFI:OTC) is a holding company featuring technology-centric direct-to-consumer and B2B health and wellness programs aimed at containing costs, improving productivity, and enhancing the quality of medical encounters. EffTec’s Strategic Business Unit, TeleCare Partners Group (www.telecarepg.com), develops and manages telemedicine programs for the eldercare sector, as well as for municipalities, and not-for-profit organizations. TeleCare Partners Group specializes in reducing unnecessary hospital readmissions at Skilled Nursing Facilities.

To better reflect its new technology-related business model EffTec International is in the process of changing its name to “Nexteligent Holdings, Inc.” and will secure a new ticker symbol.

Shareholders and interested parties seeking additional information can please call 844-777-0211 or email investor@teligentcare.com.

About TeleCare Partners Group

TeleCare Partners Group serves the needs of CMOs, medical directors, medical teams, patients, and their families.

Our unique and proprietary Readmissions Reductions Solution Program delivers tangible benefits to your operation.

We customize meaningful solutions that help you address regulatory guidelines regarding hospital readmissions, as well as unfolding developments pertaining to value-based payments, and operational excellence.

Targeted Telemedicine Solutions for Reducing Readmissions

Potentially Avoidable Hospitalizations (PAH) for skilled nursing facility residents are costly, expose patients to health risks, and exact a toll on patients and families. Many readmissions occur when there is no physician or nurse practitioner readily available, or when an immediate response is to send a patient to the ED.

TeleCare Partners Group delivers end-to-end comprehensive telemedicine program administration and measurable ROI for Skilled Nursing Facilities.

Our comprehensive program will support your initiatives to:
Improve quality of care
Manage readmissions
Create differentiation in the marketplace
Establish preferred provider status with hospitals
We are dedicated to helping you fulfill your goals in the following areas:
Financial – Fewer unnecessary readmissions mean mitigating loss of patient “bed days,” which increase SNF revenue, immediately

Measurable ROI – By tracking key metrics and reporting monthly we enable SNFs to track financial goals

Enhanced Care – Eliminating unnecessary admissions help patients avoid the stress and trauma of transportation, hospitalization and the risk of additional illness

Creating differentiation in the marketplace – Tangibly demonstrate your SNF’s commitment to achieving best-in-class clinical outcomes

Improving family interaction/engagement – Patients and families rest easy knowing that bedside consult is always available

TPG program features include:
24/7/365 access to our Board Certified physician network for immediate consults according to your facility protocols
World-class equipment and technology delivered by our experts and monitored after setup to ensure continual connectivity
24/7/365 Call Center to provide “Gold Standard” level of client support
Dedicated support before, during, and after implementation to ensure success at all stages of our engagement and fullest utilization
Studies conclude that:
20% of hospital readmissions occur within 30 days of discharge
A substantial portion of readmissions occur within the first two days of discharge
Two thirds of readmissions are Potentially Avoidable Hospitalizations (PAH)
Hospitals face financial penalties for high readmission rates and are seeking SNFs with targeted intervention programs in place
Knowles Home Assisted Living and Adult Day Services Selects TeleCare Partners Group for Telemedicine

Specialty Division of EffTec International to Launch Program in Tennessee

Knowles Home, located in Nashville, Tennessee, is part of the Metropolitan Hospital Authority and has been serving clients in the Nashville area for over 100 years.

Dr . Kendall Brune, Managing Member for Knowles Home Assisted Living and Adult Day Services noted: “Our hope is that with the help of TeleCare Partners Group, seventy-five percent of our resident transfers can be avoided. Additionally, through advanced telemedicine services, the quality of life and residential personal care will be enhanced at Knowles and the Greater Bordeaux Community.”

Dr . Brune is acknowledged for his leadership in the senior care sector. He is the 2019 recipient of the American College of Health Care Administrators (ACHCA) Outstanding Member Award and is recognized for promoting excellence in leadership among long-term care administrators.

Paul Cristiano, Chief Executive Officer, EffTec International said: “We are excited to work with Dr . Brune and are proud to support Knowles Home in its vision for enhancing resident care through telemedicine.”

The Smart Money Is Investing In EFFI

32Group Makes $ 320,000 Equity Investment Into EFFI

In May, the Company announced that it has entered into an agreement with 32Group, Inc. headquartered in Paris, France. Majid Pishyar, Chairman and CEO of 32Group, will join EffTec’s Board of Directors to help the company expand its services internationally. Additionally, 32Group has made a $ 320,000 equity investment into EffTec at $ .15 per share.

“We are pleased to partner with such a prestigious international firm that is uniquely positioned within the major world economies,” commented EffTec CEO , Paul Cristiano. “The extensive global knowledge base of 32Group will assist us as we continue to grow domestically and internationally.”

32Group Chairman and CEO , Majid Pishyar, noted: “32Group offers its products and services across five continents. The important health and wellness work that EffTec is leading, aligns with our own company vision. We believe the model and products offered by EffTec are on point in today’s developing healthcare technology environment and as part of our commitment 32Group has completed a $320,000 investment in EffTec to help expand its global footprint.”

Market Outlook

By 2030 the population of American's over 65 will increase by over 50%.

The U.S. healthcare economy is nearly as big as Germany's entire economy. U.S. healthcare spending grew 3.9% to $3.5 trillion in 2017, consuming nearly 18% of the country's gross domestic product, according to the CMS .

Higher healthcare spending limits economic growth. It stunts wages, produces higher out-of-pocket costs that dent disposable income and boosts federal subsidies for insurance bought through the Affordable Care Act exchanges.

About 33% of total healthcare spending is directed toward hospital care, translating to about 6% of total GDP, according to CMS data.

"If you look over the last 20 to 30 years, total employee compensation has gone up, but the amount each worker gets paid has been incredibly flat," Cooper said. "The gains they would've gotten in income have gone toward paying their insurance and the largest chunk of that goes toward paying their local hospital."

Healthcare inflation in the U.S. is projected to grow by an average of 5.5% annually from 2017 to 2026, ultimately reaching $5.7 trillion by 2026, the CMS estimates.

The North America Telemedicine Market was valued at USD 12.477 billion in 2018 and it is projected to reach USD 43.379 billion by 2025, increasing at a CAGR of 19.97% during the forecast period from 2019 to 2026.

Telemedicine is the delivery of healthcare assistance in remote locations utilizing telecommunications technology. This market has been emerged in the last several years. With an advance in technology, internet, and telephones, telemedicine is now quickly accessible to the general population. In extension, it has taken the burden off the current healthcare setups.

Telemedicine services are applied in different medical areas including consultation, operation, diabetes, psychiatry, radiology, dermatology pathology, cardiology, and others. Hospitals and clinics cater assistance to the critically ill, extraneous patients through an easy phone call or by video conferencing. Hospitals, Clinics and Residential (Homecare) with telecommunications technology are end-users of this market.

Technical Analysis

Based on our very own chart analysis, it appears that a bullish reversal is in the making, and we could see a move of over +100% from here!

As we stated above, over the past two weeks shares of EFFI are quietly up over +125%, and we believe that the momentum is just getting started.

The Company closed out today's session up over +21% on light volume .

We've looked into the trading history of EFFI, and it appears to move on air.

Back on April 24th, shares of EFFI more than doubled on light volume .

The Company is still well off from its 52-week high of $0.35, so this bullish reversal still has plenty of room to run.

In fact, run back to its 52-week high from today's alert price would net traders over +288% in realistic profit from today's alert price.
The Bottom Line

After bottoming out last month, EFFI has quietly been one of hottest stocks on the OTC.

We believe its upward momentum will continue on for more substantial gains.

That being said, we ask that you start your research on EFFI immediately and consider building a position tomorrow morning at 9:30AM EST

(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)


Best Regards,




DISCLAIMER

This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.



MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated seventeen thousand dollars by One 22 Media LLC to conduct a 1-day investor relations advertising marketing campaign for EFFI. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.


We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our App on Google Play! dexwirenews.com/APP

2) Text Message Notifications: dexwirenews.com/SMS

3) Telegram: t.me/DEXWireNews

4) Follow Us on our Social Networks
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.